Quality of Life in Primary Hyperparathyroidism.
Cognition
Neurologic
Neuropsychiatric
Primary hyperparathyroidism
Quality of life
Journal
Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
entrez:
16
10
2022
pubmed:
17
10
2022
medline:
19
10
2022
Statut:
ppublish
Résumé
Quality of life is impaired in primary hyperparathyroidism (PHPT), regardless of the severity of the disease. Clinical studies have employed different instruments, including standardized and disease-specific questionnaires, and including patients with different phenotypes of PHPT. Neuropsychiatric symptoms and decline in cognitive status are common in PHPT. Patients may complain of these issues or they can be ascertained by questionnaires; they include depression, anxiety, impaired vitality, social and emotional functions, sleep disturbances, and altered mental function. Randomized controlled trials on the effects of surgical versus non-surgical treatments have collectively shown improvement in quality of life after parathyroidectomy, but results have been heterogeneous.
Identifiants
pubmed: 36244696
pii: S0889-8529(22)00038-X
doi: 10.1016/j.ecl.2022.04.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
837-852Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.